Crandell Keith — insider trades

Stock trades Crandell Keith reported on SEC Form 4 at CTY CITY THERAPEUTICS, INC., BOLD Boundless Bio, Inc., KARD Kardigan, Inc., SPTX Seaport Therapeutics, Inc., LYEL Lyell Immunopharma, Inc..

• Oct 19, 2026: bought 170,000 shares of CTY CITY THERAPEUTICS, INC. ($3.06M)
• Jul 1, 2026: sold 16,000 shares of BOLD Boundless Bio, Inc. ($39.8K)
• Jun 22, 2026: bought 1,250,000 shares of KARD Kardigan, Inc. ($20.0M)
• May 4, 2026: bought 1,100,000 shares of SPTX Seaport Therapeutics, Inc. ($19.8M)
• Mar 6, 2026: bought 488,090 shares of LYEL Lyell Immunopharma, Inc. ($12.5M)
• Oct 27, 2025: bought 1,915,700 shares of NMRA Neumora Therapeutics, Inc. ($5.00M)
• Aug 1, 2025: bought 3,030,300 shares of PRME Prime Medicine, Inc. ($10.00M)
• Feb 3, 2025: bought 2,222,222 shares of MTSR Metsera, Inc. ($40.0M)